Unicenter double-blind, cross-over, randomised, placebo controlled cli
Unicenter double-blind, cross-over, randomised, placebo controlled clinical trial to evaluate efficacy of vardenafil in subjects with E.D. and multiple sclerosis (M.S.)
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Vardenafil
What it measured
Main measures
Punctuation obtained on the erectile function domain of the International Index of Erectile Function questionnaire (Questions 1-5 and 15 of the IIEF).
Bladder, bowel and sexual function
Who could take part
MS (type not specified)
Show the full criteria
Inclusion criteria
Inclusion: 1. Men who have had erectile dysfunction for at least six months according to the National Institutes of Health (NIH) Consensus Conference December 7-9, 1992 . Exclusion: 1. Any unstable medical, psychiatric, or substance abuse disorder that in the opinion of the Investigator is likely to affect the patient’s ability to complete the study or precludes the patient’s participation in the study.
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Evaluation of the efficacy placebo controlled of flexible doses of vardenafil on the erectile function (punctuation obtained on the erectile function domain of the IIEF questionnaire) in patients affected of multiple sclerosis and erectile dysfunction.
Loading reviews and guidelines…
History
Started
Jan 2006